SLC45A3 and neoplasm: SLC45A3-ERG, identified in 2/115 (1.7%) tumours from African patients, after TMPRSS2-ERG is the second most common fusion event in ERG positive PCa tumours [35], while SLC45A3-ETV1 fusion has also been reported [36].